AlphaCrest Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$706K Buy
2022
Q2
$337K Sell
2022
Q1
$1.47M Buy
2021
Q4
Sell
2021
Q3
$228K Buy
2021
Q2
$251K Sell
2021
Q1
$891K Buy
2020
Q4
$483K Buy
2020
Q3
$230K Buy
2020
Q2
Sell
2020
Q1
$436K Buy